Monthly Archives: October 2022
Letter to the Editor regarding “The Rising Burden of Inflammatory Bowel Disease in Denmark over Two Decades: A Nationwide Cohort Study” by Agrawal et al
Microbial Riboflavin Biosynthesis Associates with Response to Dietary Fiber Consumption: Time to Personalize Adjunct Therapy in Patients with Inflammatory Bowel Disease?
Intestinal barrier healing is superior to endoscopic and histologic remission for predicting major adverse outcomes in IBD: the prospective ERIca trial
Endoscopic and histologic remission have emerged as key therapeutic goals in the management of inflammatory bowel diseases (IBD) that are associated with favorable long-term disease outcomes. Here, we prospectively compared the predictive value of barr… Continue reading
Pitting Edema in a Patient with Acute Hepatitis B Virus Infection
An unusual case of chest pain and pyrexia
G9a Modulates Lipid Metabolism in CD4 T cells to Regulate Intestinal Inflammation
/Aims: Although T cell intrinsic expression of G9a has been associated with murine intestinal inflammation, mechanistic insight into the role of this methyltransferase in human T cell differentiation is ill-defined and manipulation of G9a function for … Continue reading
Massive single lesion in a patient with sickle cell disease
An unusual cause of lower gastrointestinal bleed
A Mysterious Case of Abdominal Pain!
Qualitative Improvement Initiative to Improve Helicobacter pylori Testing and Treatment After Diagnosis of Gastroduodenal Ulcers
Helicobacter pylori (H. pylori) infection is a common cause of gastroduodenal ulcers (GDU), and current guidelines recommend eradication of H. pylori to promote healing of GDU and prevention of H. pylori-associated diseases. We aimed to quantify and im… Continue reading